comparemela.com

Latest Breaking News On - Virgin group founder - Page 14 : comparemela.com

Space Travel for the Entrepreneurs: What s the Rush?

Space Travel for the Entrepreneurs: What s the Rush?
siliconindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from siliconindia.com Daily Mail and Mail on Sunday newspapers.

23andMe to Merge with Virgin Group s VG Acquisition Corp to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics February 4, 2021 23andMe is a leading consumer genetics and research company that offers a personalized health and wellness experience and has built a premier genetic database to unlock insights leading to the rapid discovery of promising new targets for drug development Transaction will provide the capital to fund additional investment in key growth initiatives across 23andMe’s consumer health and therapeutics businesses The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billion

23andMe to Merge with Virgin Group s VG Acquisition Corp to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics

23andMe to Merge with Virgin Group s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics - 23andMe is a leading consumer genetics and research company that offers a personalized health and wellness experience, and has built a premier genetic database to unlock insights leading to the rapid discovery of promising new targets for drug development - Transaction will provide the capital to fund additional investment in key growth initiatives across 23andMe s consumer health and therapeutics businesses - The transaction will value the outstanding shares of capital stock of 23andMe at an aggregate enterprise value of approximately $3.5 billion

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.